Skip to main content

Table 2 Adverse events

From: Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

 Vaccinated patients
(n = 21)a
 
 Grade 1–2Grade ≥ 3
Reported toxicity (CTCAE 4.0)  
Any toxicity210
Anemia150
Flu-like symptomsb100
Hypoalbuminemia100
Fatiguec80
Upper respiratory infection40
Dizziness30
Hematoma30
Lymphopenia30
Hypophosphatemia30
Injection site reaction20
Fever20
Headached20
AST20
Otherse10
  1. AST aspartate aminotransferase, CTCAE 4.0 Common Terminology Criteria for Adverse Events version 4.0
  2. aattributed by investigators
  3. bflu-like symptoms include fever, fatigue, chills, body aches, malaise, loss of appetite and headache
  4. cfatigue was mentioned separately when it lasted at least 1 day longer than the other flu-like symptoms or when it was present without the other flu-like symptoms
  5. dheadache was mentioned separately when it was present apart from flu-like symptoms
  6. eothers include nausea (5%), vomiting (5%), diarrhea (5%), neutropenia (5%), eosinophilia (5%), thrombocytopenia (5%), increased bilirubine (5%) and gamma-glutamyltransferase (5%)